Want to see IMA full AI Analyst Report?
Ik-595
Colorectal Cancer, Pancreatic Cancer, Non-small Cell Lung Carcinoma, Malignant Melanoma, Solid Tumor, Adult, Thyroid Carcinoma, Ras (Kras Or Nras) Gene Mutation, Braf Gene Mutation, Craf Gene Mutation, Gliomas, Malignant
Phase I
Terminated
Study of IK-595 in RAS- or RAF-altered Advanced Tumors
Jan 31, 2024
―
Osimertinib, Ik-930
Solid Tumor, Solid Tumors, Adult, Malignant Pleural Mesothelioma (Mpm), Epithelioid Hemangioendothelioma (Ehe), Nf2 Deficient Mesothelioma, Other Nf2 Deficient Solid Tumors And Solid Tumors With Yap1/Taz Fusion Genes, Nf2 Deficiency, Yap1 Or Taz Gene Fusions
Phase I
Terminated
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors
Jan 07, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does ImageneBio (IMA) have in its pipeline
IMA is currently developing the following drugs: Ik-595, Osimertinib, Ik-930. These drug candidates are in various stages of clinical development as the company works toward FDA approval.